|
|
Reference
|
|
|
*** (2006) Drug database. u: de Groot LJ, Jameson L [ur.] Endocrinology, Philadelphia: Elsevier Saunders
|
|
|
*** (2010) British National Formulary. [14. 04. 2010.]; 59
|
|
|
AACE Thyroid Task Force (2006) American association of clinical endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. www.aace.com/pub/pdf/guidelines/hypo_hyper.pdf
|
|
 
|
Abraham, P., Avenell, A., McGeoch, S.C., Clark, L.F., Bevan, J.S. (2010) Antithyroid drug regimen for treating Graves hyperthyroidism. Cochrane Database Syst Rev, CD003420
|
|
|
American Thyroid Association (2004) Joint statement on the U.S. Food and Drug Administration s decision regarding bioequivalence of levothyroxine sodium. Thyroid, 14(7): 486
|
|
 
|
Bonaci-Nikolic, B., Nikolic, MM., Andrejević, S., Zoric, S., Bukilica, M. (2005) Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Research & Therapy, vol. 7, br. 5, str. R1072-R1081
|
|
5
|
Cooper, D.S. (2005) Antithyroid drugs. N Engl J Med, 352(9): 905-17
|
|
3
|
Davies, T.F., Larsen, P.R. (2003) Thyrotoxicosis. u: Larsen P.R., Kronenberg H.M., Melmed S., Polonsky K.S. [ur.] Williams Textbook of Endocrinology, Philadelphia: Saunders, 374
|
|
|
di Girolamo, G., Keller, G.A., Los, S.A.R., Schere, D., Gonzalez, C.D. (2008) Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study. Clinical therapeutics, 30(11): 2015-23
|
|
|
FDA (2009) Information for healthcare professionals: Propylthiouracil-induced liver failure. updated 06/04
|
|
|
Fish, L.H., Schwartz, H.L., Cavanaugh, J., Steffes, M.W., Bantle, J.P., Oppenheimer, J.H. (1987) Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism: Role of triiodothyronine in pituitary feedback in humans. N Engl J Med, 316(13): 764-70
|
|
|
Hennessey, J.V., Malabanan, A.O., Haugen, B.R., Levy, E.G. (2010) Adverse event reporting in patients treated with levothyroxine: Results of the pharmacovigilance task force survey of the American thyroid association, American association of clinical endocrinologists and the endocrine society. Endocr Pract, Feb 11:1-41
|
|
1
|
Martindale (2007) The complete drug reference. London: Pharmaceutical Press, CD
|
|
|
McDermott, M.T. (2009) In the clinic: Hypothyroidism. Ann Intern Med, Dec 1;151(11):ITC61
|
|
1
|
Mcgregor, A.M., Petersen, M.M., Mclachlan, S.M., Rooke, P., Smith, B.R., Hall, R. (1980) Carbimazole and the autoimmune response in Graves' disease. N Engl J Med, 303(6): 302-7
|
|
2
|
Mitsiades, N., Poulaki, V., Tseleni-Balafouta, S., Chrousos, G.P., Koutras, D.A. (2000) Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves' disease. Thyroid, 10(7): 527-32
|
|
|
Oppenheimer, J.H., Braverman, L.E., Toft, A., Jackson, I.M., Ladenson, P.W. (1995) A therapeutic controversy: Thyroid hormone treatment: When and what?. J Clin Endocrinol Metab, 80(10): 2873-83
|
|
|
Rivkees, S.A., Mattison, D.R. (2009) Ending propylthiouracil-induced liver failure in children. N Engl J Med., Apr 9;360(15):1574-5
|
|
1
|
Salvi, M., Girasole, G., Pedrazzoni, M., Passeri, M., Giuliani, N., Minelli, R., Braverman, L.E., Roti, E. (1996) Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease. J Clin Endocrinol Metab, 81(8): 2976-9
|
|
|
Smith, T.J., Bahn, R.S., Gorman, C.A. (1989) Connective tissue, glycosaminoglycans, and diseases of the thyroid. Endocrine Reviews, 10(3), 366-91
|
|
|
Sobrinho-Simões, M., Máximo, V., Rocha, A.S., Trovisco, V., Castro, P., Preto, A., Lima, J., Soares, P. (2008) Intragenic mutations in thyroid cancer. Endocrinology and metabolism clinics of North America, 37(2): 333-62, viii
|
|
|
Sonnet, E., Massart, C., Gibassier, J., Allannic, H., Maugendre, D. (1999) Longitudinal study of soluble intercellular adhesion molecule-1 (ICAM-1) in sera of patients with Graves' disease. Journal of endocrinological investigation, 22(6): 430-5
|
|
|
Todd, C.H. (2009) Management of thyroid disorders in primary care: Challenges and controversies. Postgrad Med J., Dec;85(1010):655-9
|
|
1
|
Tsatsoulis, A., Vlachoyiannopoulos, P.G., Dalekos, G.N., Johnson, E.O., Moutsopoulos, H.M. (1995) Increased serum interleukin-1 beta during treatment of hyperthyroidism with antithyroid drugs. Eur J Clin Invest, 25(9): 654-8
|
|
|
Weetman, A.P. (1994) The immunomodulatory effects of antithyroid drugs. Thyroid, 4(2): 145-6
|
|
|
Wiersinga, W.M. (2006) Hypothyroidism and Myxedema Coma. u: de Groot LJ, Jameson L. [ur.] Endocrinology, Philadelphia: Elsevier Saunders, 5 ed.p. 2081-100
|
|
|
|
|